Established in 2005, OCT is a full-service Contract Research Organization (CRO) operating in Central and Eastern Europe (CEE).
With offices in Russia, Ukraine, Belarus, Baltic States and Bulgaria and more than 85 clinical research professionals across CEE, OCT provides high quality and cost effective services to pharmaceutical, biotechnology and medical device companies.
Our headquarters are based in St. Petersburg, Russia. OCT international and highly skilled multidisciplinary team provides comprehensive product development services for biopharmaceuticals and devices.
We offer solutions across the entire spectrum of clinical research. We are dedicated to deliver high quality clinical services for studies of any size and type. We would be happy to provide clinical support for your phase I-IV clinical trials.
Professional team with experience in key therapeutic areas across Central and Eastern Europe
OCT clinical team is the key to a clinical study’s success. 95 % of OCT project Managers and CRAs have medical background and prior experience in clinical research. We believe that OCT team is one of the best teams in the industry. OCT is dedicated to employing and retaining top-notch OCT Project Managers and CRAs with experience in main therapeutic areas including
Guaranteed on-time patient recruitment in Central and Eastern Europe
In 90% of studies organized by OCT patients enrollment goals have been met ahead-of or on-time.
Due to OCT significant clinical sites and investigators database, we are able to recruit patients on-time even in exclusive orphan drug studies. OCT feasibility team contributes to our success by individual examination of each site’s enrollment potential.
The total population OCT has access to is approximately 200 million people in 7 countries. Russia, Ukraine, Belarus, Latvia, Lithuania and Estonia are a considerable market. Patients can be found easily, as the healthcare system remains highly centralized in these countries. Hence, recruiting patients into clinical trials is much easier than in other countries.
Historically, costs in Central and Eastern Europe are lower than in the USA and Western Europe. We are glad to offer our clients high quality and cost effective solutions in performing clinical trials.
Local Experts who understand local cultures, language, regulatory issues and healthcare environments
The region we operate in is complex in the sense that there are many countries, each with its own language, culture and national regulatory requirements. Our experts are based in Russia, Ukraine, Belarus, Latvia, Lithuania, Estonia and Bulgaria. We have the local knowledge and flexibility to set up and operate on a regional level. We have experienced project managers based in the region who are familiar with local requirements and cultures, this helps us to deliver services on time.
We strongly believe that each of our clients should receive the best services based on their clinical trials needs. Our medium size enables us to be a very flexible service provider. Due to the fact that OCT has operations in several Eastern European countries, we are able to provide our Clients with options as to the place of clinical trial conduct, the study environment, as well as study design – everything depends on your goals and requirements. Just give us the concept of your drug development – and we`ll apply the best decision.
Our experienced teams deliver quality results for our clients' drug research and development needs.
We have the advantage of being able to act very quickly, adapt our systems and processes to meet the needs of our customers and employees, and also respond to changes in the local markets. We can be very flexible because there is no bureaucracy in the decision making. This enables us to improve ourselves.
Although most of clinical trials conducted at OCT in Central and Eastern Europe were rescue studies for which recruitment was slow, now many OCT sponsors realize that this region should be considered when initiating global clinical trials.
Although it is absolutely true that regulations, culture and language are different in OCT countries than in Western Europe and the USA, OCT is here to help our clients to overcome possible problems in this region and enjoy all the advantages which are offered by Russia, Ukraine, Belarus, Baltic States and Bulgaria:
- Quick enrollment
- Good quality data
- Stable Regulatory environment
- Availability of good vendors
- Cost effective clinical trials
- Well educated CRO staff
OCT presence in Central and Eastern Europe (CEE)
- Clinical trials in Russia
- Clinical trials in Ukraine
- Clinical trials in Belarus
- Clinical trials in the Baltic States
- Clinical Trials in Bulgaria